These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8245722)

  • 81. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.
    Lüttmann S; von Eckardstein A; Wei W; Funke H; Köhler E; Mahley RW; Assmann G
    J Lipid Res; 1994 Aug; 35(8):1431-40. PubMed ID: 7989867
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Apolipoproteins B, C-III and E in two major subpopulations of low-density lipoproteins.
    Lee DM; Alaupovic P
    Biochim Biophys Acta; 1986 Nov; 879(2):126-33. PubMed ID: 3768392
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Structural organization of apolipoprotein B-100 of human plasma low density lipoproteins. Comparison to B-48 of chylomicrons and very low density lipoproteins.
    Cardin AD; Price CA; Hirose N; Krivanek MA; Blankenship DT; Chao J; Mao SJ
    J Biol Chem; 1986 Dec; 261(35):16744-8. PubMed ID: 3640763
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
    Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
    Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
    [No Abstract]   [Full Text] [Related]  

  • 87. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
    de Silva HV; Lauer SJ; Wang J; Simonet WS; Weisgraber KH; Mahley RW; Taylor JM
    J Biol Chem; 1994 Jan; 269(3):2324-35. PubMed ID: 8294490
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Abnormal apolipoprotein composition in alcoholic hepatitis.
    Tada N; Nestel PJ; Fidge N; Campbell G
    Biochim Biophys Acta; 1981 May; 664(2):207-20. PubMed ID: 6788090
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Changes with aging in serum lipoproteins and apolipoprotein C subclasses.
    Takeuchi N; Matsumoto A; Katayama Y; Arao M; Koga M; Nakao H; Uchida K
    Arch Gerontol Geriatr; 1983 Jul; 2(1-2):41-8. PubMed ID: 6578706
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
    Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
    Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Increased serum concentration of apolipoprotein C-III and its greater distribution to chylomicrons than to the high-density lipoprotein fraction in a calf with hyperlipidemia.
    Yamamot M; Oohashi T; Katoh N; Oikawa S
    J Vet Med Sci; 2000 Oct; 62(10):1033-9. PubMed ID: 11073072
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Familial apolipoprotein A-I and C-III deficiency, variant II.
    Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
    J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Kinetic studies of the origin of apolipoprotein (apo) B-100 in low density lipoproteins of normal and Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Havel RJ; Shames DM
    Adv Exp Med Biol; 1991; 285():245-55. PubMed ID: 1858553
    [No Abstract]   [Full Text] [Related]  

  • 96. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia: effects of plasma exchange.
    Soutar AK; Myant NB; Thompson GR
    Atherosclerosis; 1979 Mar; 32(3):315-25. PubMed ID: 223591
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins.
    Van't Hooft FM; Hardman DA; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):179-82. PubMed ID: 6948299
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins.
    Blanco-Vaca F; Via DP; Yang CY; Massey JB; Pownall HJ
    J Lipid Res; 1992 Dec; 33(12):1785-96. PubMed ID: 1479288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.